跳至主要内容
临床试验/NCT06169241
NCT06169241招募中早期 1 期

Effect of Nitrate Supplementation on Blood Pressure and Systemic Microvascular Function of Resistant Hypertensive Patients

National Institute of Cardiology, Laranjeiras, Brazil2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年11月1日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
招募中
发起方
入组人数
50
试验地点
2
主要终点
Assessment of blood pressure evolution

研究概览

简要总结

Arterial hypertension (AH) has been identified as an important public health problem and considered a new epidemic with high mortality and morbidity. High blood pressure (BP) levels increase the chances of coronary artery disease (CAD), heart failure (HF), stroke, chronic renal failure (CRF) and death. Beetroot powder may be an easier way to increase the availability of nitric oxide and consequently vasodilation in these patients. However, studies are needed to evaluate its benefits in patients with AH.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Resistant hypertension, with a diagnosis described in the medical record, without changing medications or increasing doses in the last 30 days.

排除标准

  • neoplasms
  • heart failure
  • use of medications with nitrate in their formula
  • patients undergoing renal denervation

研究组 & 干预措施

Placebo

Placebo Comparator

The placebo group will be administered as a colored and flavored isocaloric supplement composed of maltodextrin.

干预措施: Placebo (Dietary Supplement)

Beetroot extract

Active Comparator

Beetroot extract powder supplementation with 400mg of nitrate per dose in the amount of 10g per day orally will be used in the group.

干预措施: Beetroot extract (Dietary Supplement)

结局指标

主要结局

Assessment of blood pressure evolution

时间窗: 60 days

Evaluation using Ambulatory Blood Pressure Monitoring: systolic, diastolic and mean arterial pressures

次要结局

未报告次要终点

研究者

发起方
National Institute of Cardiology, Laranjeiras, Brazil
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Eduardo Tibirica, MD, PhD

Senior Researcher

National Institute of Cardiology, Laranjeiras, Brazil

研究点 (2)

Loading locations...

相似试验